Leukemia & lymphomaHumansImmunoglobulin Light-chain AmyloidosisMaleFemaleAged
Profound dFLC decrease after one cycle predicts superior outcome in patients with AL amyloidosis.
Yang Liu, Jingyi Bi, Xuelin Dou, Nan Peng, Lei Wen, Liru Wang, Yanqiu Zhao, Yanqing Zhang, Yongqian Zhang, Yanping Cao, Wanjing Zhang, Jin Lu
Published: 202610.1080/10428194.2025.2571200
Abstract
The relationship between an early decrease in the difference between involved and uninvolved free light chains (dFLC) and clinical outcomes in AL amyloidosis is significant. We conducted a multicenter study (n = 86, baseline dFLC ≥ 50 mg/L) in which…
Preview only. Read the full abstract at the source